Gujarat Alkalies & Chemicals Ltd
- Market Cap ₹ 4,124 Cr.
- Current Price ₹ 562
- High / Low ₹ 900 / 484
- Stock P/E
- Book Value ₹ 772
- Dividend Yield 2.81 %
- ROCE -0.34 %
- ROE -1.13 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.73 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 8.37% over past five years.
- Company has a low return on equity of 0.59% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,995 | 2,070 | 2,455 | 3,161 | 2,725 | 2,429 | 3,759 | 4,516 | 3,807 | 4,073 | 4,201 | |
| 1,660 | 1,622 | 1,669 | 2,046 | 2,148 | 2,072 | 2,774 | 3,568 | 3,775 | 3,793 | 3,880 | |
| Operating Profit | 335 | 448 | 786 | 1,115 | 577 | 357 | 984 | 949 | 32 | 279 | 321 |
| OPM % | 17% | 22% | 32% | 35% | 21% | 15% | 26% | 21% | 1% | 7% | 8% |
| 45 | 56 | 106 | 62 | 90 | 67 | 46 | 42 | 90 | 92 | 97 | |
| Interest | 10 | 13 | 15 | 21 | 14 | 15 | 6 | 19 | 45 | 51 | 53 |
| Depreciation | 107 | 111 | 127 | 140 | 162 | 174 | 198 | 276 | 377 | 392 | 398 |
| Profit before tax | 262 | 381 | 749 | 1,016 | 491 | 235 | 826 | 695 | -300 | -71 | -33 |
| Tax % | 16% | 19% | 29% | 32% | 32% | 29% | 32% | 41% | -21% | -9% | |
| 220 | 307 | 534 | 690 | 332 | 166 | 560 | 410 | -237 | -65 | -34 | |
| EPS in Rs | 29.90 | 41.85 | 72.78 | 93.98 | 45.22 | 22.57 | 76.22 | 55.78 | -32.25 | -8.87 | -4.69 |
| Dividend Payout % | 15% | 12% | 9% | 9% | 18% | 35% | 13% | 42% | -43% | -178% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 3% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 85% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 11% |
| 3 Years: | -14% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 1% |
| Last Year: | -1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 |
| Reserves | 2,854 | 3,282 | 3,748 | 4,222 | 4,522 | 5,301 | 5,826 | 6,066 | 6,002 | 5,596 |
| 295 | 353 | 291 | 247 | 205 | 498 | 594 | 597 | 544 | 561 | |
| 671 | 726 | 859 | 988 | 1,090 | 1,282 | 1,484 | 1,599 | 1,404 | 1,756 | |
| Total Liabilities | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 |
| 1,821 | 2,073 | 2,104 | 2,300 | 2,610 | 2,587 | 2,702 | 4,250 | 4,617 | 4,584 | |
| CWIP | 83 | 151 | 252 | 307 | 445 | 1,109 | 1,787 | 544 | 95 | 79 |
| Investments | 854 | 1,016 | 1,145 | 1,065 | 1,242 | 2,092 | 2,110 | 1,831 | 2,093 | 1,976 |
| 1,136 | 1,196 | 1,469 | 1,858 | 1,594 | 1,366 | 1,379 | 1,710 | 1,218 | 1,348 | |
| Total Assets | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 201 | 502 | 514 | 838 | 630 | 421 | 735 | 960 | 67 | 381 | |
| -352 | -467 | -395 | -581 | -634 | -334 | -804 | -662 | -90 | -264 | |
| 84 | 13 | -116 | -136 | -146 | 226 | 12 | -140 | -277 | -145 | |
| Net Cash Flow | -67 | 49 | 3 | 122 | -150 | 313 | -58 | 158 | -301 | -28 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 58 | 60 | 56 | 50 | 43 | 29 | 23 | 17 | 24 |
| Inventory Days | 99 | 94 | 147 | 99 | 92 | 88 | 101 | 111 | 93 | 110 |
| Days Payable | 99 | 125 | 154 | 134 | 126 | 111 | 101 | 119 | 86 | 115 |
| Cash Conversion Cycle | 60 | 27 | 53 | 22 | 17 | 21 | 29 | 15 | 25 | 19 |
| Working Capital Days | 89 | 81 | 98 | 96 | 107 | 10 | 4 | 5 | -1 | -3 |
| ROCE % | 11% | 18% | 24% | 11% | 5% | 13% | 11% | -4% | -0% |
Documents
Announcements
-
Intimation Regarding 100 Days Campaign - ''''Saksham Niveshak''''
1d - Notifying shareholders of IEPF 'Saksham Niveshak' 100-day KYC campaign Jul 28–Nov 6, 2025; letters sent 03.10.2025.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
27 Sep - All resolutions passed; dividend Rs15.80 per share; AGM held 26 Sep 2025.
- Shareholder Meeting / Postal Ballot-Outcome of AGM 26 Sep
-
Closure of Trading Window
26 Sep - Trading window closed from 1 Oct 2025 until 48 hours after Q2 (Sept 2025) unaudited results announcement.
-
Disclosure Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Prepayment Of External Commercial Borrowing (ECB) Facility Availed From State Bank Of India.
19 Sep - Prepaid USD 34.35M ECB from SBI; refinanced with HDFC rupee term loan; No Dues certificate 18 Sep 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
Concalls
-
Feb 2025TranscriptNotesPPT
-
Jun 2024TranscriptNotesPPT
-
Mar 2024TranscriptNotesPPT
-
Dec 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Jun 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Jun 2019TranscriptNotesPPT
-
Mar 2017TranscriptNotesPPT
-
May 2016TranscriptPPT
Product Offerings
The company has over 36 products in its portfolio, including Caustic Soda lye, flakes, and prills, Chloromethanes, Liquid Chlorine, Hydrochloric Acid, Hydrogen Peroxide, Anhydrous Aluminum Chloride, Caustic Potash lye and flakes, Potassium Carbonate granules and powder, Aluminium Chloride, Phosphoric Acid, etc. These products are utilized across industries such as textiles, pulp and paper, alumina, soaps& detergents, and water treatment, etc. [1]